Yield of overnight pulse oximetry in screening commercial drivers for obstructive sleep apnea.

Autor: Adami A; Sleep Center, Neurology Dept, IRCCS Sacro Cuore Don Calabria, Via Sempreboni 6, 37024, Negrar, Verona, Italy. alessandro.adami@sacrocuore.it., Tonon D; Sleep Center, Neurology Dept, IRCCS Sacro Cuore Don Calabria, Via Sempreboni 6, 37024, Negrar, Verona, Italy., Corica A; Sleep Center, Neurology Dept, IRCCS Sacro Cuore Don Calabria, Via Sempreboni 6, 37024, Negrar, Verona, Italy., Trevisan D; Sleep Center, Neurology Dept, IRCCS Sacro Cuore Don Calabria, Via Sempreboni 6, 37024, Negrar, Verona, Italy., Thijs V; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg, VIC, Australia., Rossato G; Sleep Center, Neurology Dept, IRCCS Sacro Cuore Don Calabria, Via Sempreboni 6, 37024, Negrar, Verona, Italy.

Publikováno v: Sleep & breathing = Schlaf & Atmung [Sleep Breath] 2023 Dec; Vol. 27 (6), pp. 2175-2180. Date of Electronic Publication: 2023 Mar 27.

Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab.

Autor: Nabbi A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Danesh A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Espin-Garcia O; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.; Dalla Lana School of Public Health and Department of Statistical Sciences, University of Toronto, Toronto, Ontario, Canada., Pedersen S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Wellum J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Fu LH; Clinical Biomarker Operations, Product Development Oncology, Genentech, South San Francisco, CA, USA., Paulson JN; Department of Biostatistics, Product Development, Genentech, South San Francisco, CA, USA., Geoerger B; Gustave Roussy Cancer Centre, Department of Pediatric and Adolescent Oncology, INSERM U1015, Université Paris-Saclay, Villejuif, France., Marshall LV; The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, UK., Trippett T; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rossato G; Product Development Clinical Oncology, F. Hoffmann-La Roche, Basel, Switzerland., Pugh TJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. trevor.pugh@utoronto.ca.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. trevor.pugh@utoronto.ca.; Ontario Institute for Cancer Research, Toronto, Ontario, Canada. trevor.pugh@utoronto.ca., Hutchinson KE; Oncology Biomarker Development, Genentech, South San Francisco, CA, USA. hutchinson.katherine@gene.com.

Publikováno v: Nature cancer [Nat Cancer] 2023 Apr; Vol. 4 (4), pp. 502-515. Date of Electronic Publication: 2023 Apr 10.

Mirror Full Adder SET Susceptibility on 7nm FinFET Technology

Autor: Ricardo Reis, Rafael N. M. Oliveira, Cristina Meinhardt, Fabio G. Rossato G. da Silva

Publikováno v: ICECS

This work investigates the Mirror full adder circuit using a 7nm FinFET technology, considering the SET susceptibility and the robustness of all internal nodes of the circuit. This work aims to identify how this full adder topology behaves in a speci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f6a0e983f1e02e7b48ab6a56e99e4c4d
https://doi.org/10.1109/icecs49266.2020.9294891

Microencapsulation of Yarrowia lipolytica: cell viability and application in vitro ruminant diets.

Autor: Dos Santos Wanderley LA; Department of Food and Chemical Engineering, URI - Erechim, 1621, Sete de Setembro Av., Erechim, RS, 99709-910, Brazil., Aguiar GPS; Environmental Sciences Area, Community University of Chapecó Region (Unochapecó), Servidão Anjo da Guarda, 295-D, Bairro Efapi, Chapecó, SC, 89809-900, Brazil., Calisto JFF; Environmental Sciences Area, Community University of Chapecó Region (Unochapecó), Servidão Anjo da Guarda, 295-D, Bairro Efapi, Chapecó, SC, 89809-900, Brazil., Magro JD; Environmental Sciences Area, Community University of Chapecó Region (Unochapecó), Servidão Anjo da Guarda, 295-D, Bairro Efapi, Chapecó, SC, 89809-900, Brazil., Rossato G; Department of Animal Science, University of West Santa Catarina, Xanxerê, SC, 89820-000, Brazil., Zotti CA; Department of Animal Science, University of West Santa Catarina, Xanxerê, SC, 89820-000, Brazil., de Souza Hassemer G; Department of Food and Chemical Engineering, URI - Erechim, 1621, Sete de Setembro Av., Erechim, RS, 99709-910, Brazil., Puton BMS; Department of Food and Chemical Engineering, URI - Erechim, 1621, Sete de Setembro Av., Erechim, RS, 99709-910, Brazil., Cansian RL; Department of Food and Chemical Engineering, URI - Erechim, 1621, Sete de Setembro Av., Erechim, RS, 99709-910, Brazil., Dallago RM; Department of Food and Chemical Engineering, URI - Erechim, 1621, Sete de Setembro Av., Erechim, RS, 99709-910, Brazil., Junges A; Department of Food and Chemical Engineering, URI - Erechim, 1621, Sete de Setembro Av., Erechim, RS, 99709-910, Brazil. junges@uricer.edu.br.

Publikováno v: World journal of microbiology & biotechnology [World J Microbiol Biotechnol] 2023 Feb 06; Vol. 39 (4), pp. 88. Date of Electronic Publication: 2023 Feb 06.

Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

Autor: Pearson AD; ACCELERATE, Europe. Electronic address: andy1pearson@btinternert.com., Allen C; Texas Children Hospital, Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA., Fangusaro J; Children's Healthcare of Atlanta, USA; Emory University School of Medicine, Atlanta, USA., Hutter C; St. Anna Children's Hospital, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria., Witt O; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Heidelberg University Hospital, Heidelberg, Germany; German Cancer Research Center, Heidelberg, Germany., Weiner S; Children's Cancer Cause, Washington DC, USA., Reaman G; US Food and Drug Administration, Silver Springs, USA., Russo M; Novartis, New Jersey, USA., Bandopadhayay P; Department of Pediatrics, Harvard Medical School, Broad Institute, USA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, USA., Ahsan S; Merck & Co., Inc, Rahway, NJ, USA., Barone A; US Food and Drug Administration, Silver Springs, USA., Barry E; Day One Biopharmaceuticals, San Francisco, USA., de Rojas T; ACCELERATE, Europe., Fisher M; The Children's Hospital of Philadelphia, Philadelphia, USA., Fox E; St Jude Children's Research Hospital, Tennessee, USA., Bender JG; Memorial Sloan Kettering Cancer Centre, New York, USA., Gore L; Children's Hospital Colorado, USA; University of Colorado, USA., Hargrave D; UCL Great Ormond Street Institute of Child Health, London UK., Hawkins D; Seattle Children's Hospital, USA; Children's Oncology Group, Seattle, USA., Kreider B; BioMed Valley Discoveries, Kansas City, MO, USA., Langseth AJ; SpringWorks Therapeutics, Stamford, CT, USA., Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Netherlands., Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Netherlands., Marotti M; Boehringer Ingelheim, Germany., Marshall LV; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK., Nasri K; Pierre-Fabre, Paris, France., Norga K; Antwerp University Hospital, Antwerp, Belgium; Paediatric Committee of the European Medicines Agency, (EMA), Netherlands; Federal Agency for Medicines and Health Products, Brussels, Belgium., Nysom K; Righospitalet, Copenhagen, Denmark., Pappo A; St Jude Children's Research Hospital, Tennessee, USA., Rossato G; F. Hoffmann-La Roche AG, Basel, Switzerland., Scobie N; Zoe4Life, Sullens, Switzerland., Smith M; National Cancer Institute, Maryland, USA., Stieglitz E; UCSF Benioff Children's Hospital San Francisco, USA., Weigel B; University of Minnesota, Minneapolis, USA., Weinstein A; Pediatric Brain Tumor Foundation, Atlanta, USA., Viana R; Alexion Pharmaceuticals, Zurich, Switzerland., Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Netherlands., Vassal G; ACCELERATE, Europe; Gustave Roussy Cancer Centre, Paris, France.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Dec; Vol. 177, pp. 120-142. Date of Electronic Publication: 2022 Oct 14.